<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Fernandez-Suarez E</submitter><funding>Instituto de Salud Carlos III</funding><funding>Consejería de Salud y Familias, Junta de Andalucía</funding><funding>Fundación Isabel Gemio</funding><pagination>1197744</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10401274</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11</volume><pubmed_abstract>Inherited retinal dystrophies (IRDs) are a clinically and genetically heterogeneous group of disorders that often severely impair vision. Some patients manifest poor central vision as the first symptom due to cone-dysfunction, which is consistent with cone dystrophy (COD), Stargardt disease (STGD), or macular dystrophy (MD) among others. Here, we aimed to identify the genetic cause of autosomal dominant COD in one family. WGS was performed in 3 affected and 1 unaffected individual using the TruSeq Nano DNA library kit and the NovaSeq 6,000 platform (Illumina). Data analysis identified a novel spliceogenic variant (c.283 + 1G>A) in the thyroid hormone receptor beta gene (&lt;i>THRB&lt;/i>) as the candidate disease-associated variant. Further genetic analysis revealed the presence of the same hete</pubmed_abstract><journal>Frontiers in cell and developmental biology</journal><pubmed_title>Expanding the phenotype of &lt;i>THRB&lt;/i>: a range of macular dystrophies as the major clinical manifestations in patients with a dominant splicing variant.</pubmed_title><pmcid>PMC10401274</pmcid><funding_grant_id>PEER-0501-2019 RH-0049-2021</funding_grant_id><funding_grant_id>FGEMIO-2019-01</funding_grant_id><funding_grant_id>PI21-00244 IMP-0009 FI19/00091</funding_grant_id><pubmed_authors>Fernandez-Suarez E</pubmed_authors><pubmed_authors>Garcia-Nunez A</pubmed_authors><pubmed_authors>Mendez-Vidal C</pubmed_authors><pubmed_authors>Mejias-Carrasco JM</pubmed_authors><pubmed_authors>Antinolo G</pubmed_authors><pubmed_authors>Rodriguez-de la Rua E</pubmed_authors><pubmed_authors>Borrego S</pubmed_authors><pubmed_authors>Ramos-Jimenez M</pubmed_authors><pubmed_authors>Gonzalez-Del Pozo M</pubmed_authors><pubmed_authors>Martin-Sanchez M</pubmed_authors><pubmed_authors>Morillo-Sanchez MJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Expanding the phenotype of &lt;i>THRB&lt;/i>: a range of macular dystrophies as the major clinical manifestations in patients with a dominant splicing variant.</name><description>Inherited retinal dystrophies (IRDs) are a clinically and genetically heterogeneous group of disorders that often severely impair vision. Some patients manifest poor central vision as the first symptom due to cone-dysfunction, which is consistent with cone dystrophy (COD), Stargardt disease (STGD), or macular dystrophy (MD) among others. Here, we aimed to identify the genetic cause of autosomal dominant COD in one family. WGS was performed in 3 affected and 1 unaffected individual using the TruSeq Nano DNA library kit and the NovaSeq 6,000 platform (Illumina). Data analysis identified a novel spliceogenic variant (c.283 + 1G>A) in the thyroid hormone receptor beta gene (&lt;i>THRB&lt;/i>) as the candidate disease-associated variant. Further genetic analysis revealed the presence of the same hete</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2026-05-28T20:32:14.328Z</modification><creation>2024-11-07T10:04:20.644Z</creation></dates><accession>S-EPMC10401274</accession><cross_references><pubmed>37547476</pubmed><doi>10.3389/fcell.2023.1197744</doi></cross_references></HashMap>